Zerigo Health

Executive Summary

Zerigo Health is a digital health company transforming the management of chronic skin conditions such as psoriasis, eczema, and vitiligo. Its core offering is an FDA-cleared, portable narrowband UVB phototherapy device paired with a connected mobile app and a holistic care program. This integrated solution enables patients to undergo effective at-home treatment, improving adherence and outcomes while reducing the burden on the healthcare system. Founded in 2015 and headquartered in San Diego, the company is privately held and has gained traction as a leader in teledermatology and home-based phototherapy. The company's value proposition lies in making proven phototherapy more accessible, convenient, and data-driven. By combining a medical device with digital coaching, remote monitoring, and personalized care plans, Zerigo Health empowers patients to take control of their condition while providing clinicians with real-time insights. As the digital health market expands, particularly in dermatology, Zerigo Health is well-positioned to scale its platform through partnerships, clinical evidence, and regulatory expansions. With a growing patient population seeking alternatives to systemic medications, Zerigo Health offers a non-invasive, drug-free option with a strong safety profile.

Upcoming Catalysts (preview)

• Q3 2026FDA clearance for expanded pediatric indication or vitiligo population70% success
• Q4 2026Strategic partnership with a large pharmacy chain or payer for nationwide distribution60% success
• Q2 2026Publication of real-world evidence study demonstrating long-term efficacy in atopic dermatitis80% success